We demonstrated that CD8+ OT-I cells pre-treated with Fβ2 recognized tumor cells more efficiently and that this recognition was enhanced when tumor cells were pretreated with Fβ2 (Fig. 4C-D). This evidence concerns the gene CD8A and neoplasm.